Submit Feedback
Learn more about CVS Health Corp.'s Revenue by Segment and Revenue by Region.
Check out competitors to CVS Health Corp. in a side-by-side comparison.
Explore additional financial metrics for CVS Health Corp..
| 2015 | 153290000000.00 |
|---|---|
| 2016 | 177546000000.00 |
| 2017 | 184786000000.00 |
| 2018 | 194579000000.00 |
| 2019 | 256776000000.00 |
| 2020 | 268706000000.00 |
| 2021 | 292111000000.00 |
| 2022 | 322467000000.00 |
| 2023 | 357776000000.00 |
| 2024 | 372809000000.00 |
| 2025 | 402067000000.00 |
| Mar 2016 | 43215000000.00 |
|---|---|
| Jun 2016 | 43725000000.00 |
| Sep 2016 | 44615000000.00 |
| Dec 2016 | 45971000000.00 |
| Mar 2017 | 44514000000.00 |
| Jun 2017 | 45685000000.00 |
| Sep 2017 | 46181000000.00 |
| Dec 2017 | 48385000000.00 |
| Mar 2018 | 45743000000.00 |
| Jun 2018 | 46922000000.00 |
| Sep 2018 | 47490000000.00 |
| Dec 2018 | 54909000000.00 |
| Mar 2019 | 61646000000.00 |
| Jun 2019 | 63431000000.00 |
| Sep 2019 | 64810000000.00 |
| Dec 2019 | 66889000000.00 |
| Mar 2020 | 66755000000.00 |
| Jun 2020 | 65341000000.00 |
| Sep 2020 | 67056000000.00 |
| Dec 2020 | 69554000000.00 |
| Mar 2021 | 69097000000.00 |
| Jun 2021 | 72616000000.00 |
| Sep 2021 | 73794000000.00 |
| Dec 2021 | 76604000000.00 |
| Mar 2022 | 76826000000.00 |
| Jun 2022 | 80636000000.00 |
| Sep 2022 | 81159000000.00 |
| Dec 2022 | 83846000000.00 |
| Mar 2023 | 85278000000.00 |
| Jun 2023 | 88921000000.00 |
| Sep 2023 | 89764000000.00 |
| Dec 2023 | 93813000000.00 |
| Mar 2024 | 88437000000.00 |
| Jun 2024 | 91234000000.00 |
| Sep 2024 | 95428000000.00 |
| Dec 2024 | 97710000000.00 |
| Mar 2025 | 94588000000.00 |
| Jun 2025 | 98915000000.00 |
| Sep 2025 | 102871000000.00 |
| Dec 2025 | 105693000000.00 |
| Mar 2026 | 100426000000.00 |
| Jun 2026 | 106096000000.00 |
CVS Health Corp.'s annual revenue was $402.07 B in fiscal year 2025.
CVS Health Corp.'s quarterly revenue was $94.59 B(Q1: Mar 2025), $98.92 B(Q2: Jun 2025), $102.87 B(Q3: Sep 2025), $105.69 B(Q4: Dec 2025) in fiscal year 2025.
CVS Health Corp.'s annual revenue was $372.81 B in fiscal year 2024.
CVS Health Corp.'s quarterly revenue was $88.44 B(Q1: Mar 2024), $91.23 B(Q2: Jun 2024), $95.43 B(Q3: Sep 2024), $97.71 B(Q4: Dec 2024) in fiscal year 2024.
CVS Health Corp.'s annual revenue was $357.78 B in fiscal year 2023.
CVS Health Corp.'s quarterly revenue was $85.28 B(Q1: Mar 2023), $88.92 B(Q2: Jun 2023), $89.76 B(Q3: Sep 2023), $93.81 B(Q4: Dec 2023) in fiscal year 2023.
CVS Health Corp.'s annual revenue was $322.47 B in fiscal year 2022.
CVS Health Corp.'s quarterly revenue was $76.83 B(Q1: Mar 2022), $80.64 B(Q2: Jun 2022), $81.16 B(Q3: Sep 2022), $83.85 B(Q4: Dec 2022) in fiscal year 2022.
CVS Health Corp.'s annual revenue was $292.11 B in fiscal year 2021.
CVS Health Corp.'s quarterly revenue was $69.10 B(Q1: Mar 2021), $72.62 B(Q2: Jun 2021), $73.79 B(Q3: Sep 2021), $76.60 B(Q4: Dec 2021) in fiscal year 2021.
CVS Health Corp.'s annual revenue was $268.71 B in fiscal year 2020.
CVS Health Corp.'s quarterly revenue was $66.76 B(Q1: Mar 2020), $65.34 B(Q2: Jun 2020), $67.06 B(Q3: Sep 2020), $69.55 B(Q4: Dec 2020) in fiscal year 2020.
CVS Health Corp.'s annual revenue was $256.78 B in fiscal year 2019.
CVS Health Corp.'s quarterly revenue was $61.65 B(Q1: Mar 2019), $63.43 B(Q2: Jun 2019), $64.81 B(Q3: Sep 2019), $66.89 B(Q4: Dec 2019) in fiscal year 2019.
CVS Health Corp.'s annual revenue was $194.58 B in fiscal year 2018.
CVS Health Corp.'s quarterly revenue was $45.74 B(Q1: Mar 2018), $46.92 B(Q2: Jun 2018), $47.49 B(Q3: Sep 2018), $54.91 B(Q4: Dec 2018) in fiscal year 2018.
CVS Health Corp.'s annual revenue was $184.79 B in fiscal year 2017.
CVS Health Corp.'s quarterly revenue was $44.51 B(Q1: Mar 2017), $45.69 B(Q2: Jun 2017), $46.18 B(Q3: Sep 2017), $48.39 B(Q4: Dec 2017) in fiscal year 2017.
CVS Health Corp.'s annual revenue was $177.55 B in fiscal year 2016.
CVS Health Corp.'s quarterly revenue was $43.22 B(Q1: Mar 2016), $43.73 B(Q2: Jun 2016), $44.62 B(Q3: Sep 2016), $45.97 B(Q4: Dec 2016) in fiscal year 2016.
| 2015 | 0 |
|---|---|
| 2016 | +15.82 |
| 2017 | +4.08 |
| 2018 | +5.30 |
| 2019 | +31.96 |
| 2020 | +4.65 |
| 2021 | +8.71 |
| 2022 | +10.39 |
| 2023 | +10.95 |
| 2024 | +4.20 |
| 2025 | +7.85 |
| Q1: Mar 16 | 18.94 |
|---|---|
| Q2: Jun 16 | 17.64 |
| Q3: Sep 16 | 15.45 |
| Q4: Dec 16 | 11.73 |
| Q1: Mar 17 | 3.01 |
| Q2: Jun 17 | 4.48 |
| Q3: Sep 17 | 3.51 |
| Q4: Dec 17 | 5.25 |
| Q1: Mar 18 | 2.76 |
| Q2: Jun 18 | 2.71 |
| Q3: Sep 18 | 2.83 |
| Q4: Dec 18 | 13.48 |
| Q1: Mar 19 | 34.77 |
| Q2: Jun 19 | 35.18 |
| Q3: Sep 19 | 36.47 |
| Q4: Dec 19 | 21.82 |
| Q1: Mar 20 | 8.29 |
| Q2: Jun 20 | 3.01 |
| Q3: Sep 20 | 3.47 |
| Q4: Dec 20 | 3.98 |
| Q1: Mar 21 | 3.51 |
| Q2: Jun 21 | 11.13 |
| Q3: Sep 21 | 10.05 |
| Q4: Dec 21 | 10.14 |
| Q1: Mar 22 | 11.19 |
| Q2: Jun 22 | 11.04 |
| Q3: Sep 22 | 9.98 |
| Q4: Dec 22 | 9.45 |
| Q1: Mar 23 | 11.00 |
| Q2: Jun 23 | 10.27 |
| Q3: Sep 23 | 10.60 |
| Q4: Dec 23 | 11.89 |
| Q1: Mar 24 | 3.70 |
| Q2: Jun 24 | 2.60 |
| Q3: Sep 24 | 6.31 |
| Q4: Dec 24 | 4.15 |
| Q1: Mar 25 | 6.96 |
| Q2: Jun 25 | 8.42 |
| Q3: Sep 25 | 7.80 |
| Q4: Dec 25 | 8.17 |
| Q1: Mar 26 | 6.17 |
| Q2: Jun 26 | 7.26 |
CVS Health Corp.โs annual revenue increased +7.85% during fiscal year 2025 compared to 2024. It represents a growth of $29.26 B from $372.81 B (in 2024) to $402.07 B (in 2025).
CVS Health Corp.โs annual revenue increased +4.20% during fiscal year 2024 compared to 2023. It represents a growth of $15.03 B from $357.78 B (in 2023) to $372.81 B (in 2024).
CVS Health Corp.โs annual revenue increased +10.95% during fiscal year 2023 compared to 2022. It represents a growth of $35.31 B from $322.47 B (in 2022) to $357.78 B (in 2023).
CVS Health Corp.โs annual revenue increased +10.39% during fiscal year 2022 compared to 2021. It represents a growth of $30.36 B from $292.11 B (in 2021) to $322.47 B (in 2022).
CVS Health Corp.โs annual revenue increased +8.71% during fiscal year 2021 compared to 2020. It represents a growth of $23.41 B from $268.71 B (in 2020) to $292.11 B (in 2021).
CVS Health Corp.โs annual revenue increased +4.65% during fiscal year 2020 compared to 2019. It represents a growth of $11.93 B from $256.78 B (in 2019) to $268.71 B (in 2020).
CVS Health Corp.โs annual revenue increased +31.96% during fiscal year 2019 compared to 2018. It represents a growth of $62.20 B from $194.58 B (in 2018) to $256.78 B (in 2019).
CVS Health Corp.โs annual revenue increased +5.30% during fiscal year 2018 compared to 2017. It represents a growth of $9.79 B from $184.79 B (in 2017) to $194.58 B (in 2018).
CVS Health Corp.โs annual revenue increased +4.08% during fiscal year 2017 compared to 2016. It represents a growth of $7.24 B from $177.55 B (in 2016) to $184.79 B (in 2017).
CVS Health Corp.โs annual revenue increased +15.82% during fiscal year 2016 compared to 2015. It represents a growth of $24.26 B from $153.29 B (in 2015) to $177.55 B (in 2016).
| Period | Revenue | Year-over-Year Change |
|---|---|---|
|
Get instant access to data, Sign up for free 
FY 2025
|
$402.07 B |
$29.26 B
7.85%
|
| Q4: Dec 25 | $105.69 B |
$7.98 B
8.17%
|
| Q3: Sep 25 | $102.87 B |
$7.44 B
7.8%
|
| Q2: Jun 25 | $98.92 B |
$7.68 B
8.42%
|
| Q1: Mar 25 | $94.59 B |
$6.15 B
6.96%
|
|
Get instant access to data, Sign up for free
FY 2024
|
$372.81 B |
$15.03 B
4.2%
|
| Q4: Dec 24 | $97.71 B |
$3.90 B
4.15%
|
| Q3: Sep 24 | $95.43 B |
$5.66 B
6.31%
|
| Q2: Jun 24 | $91.23 B |
$2.31 B
2.6%
|
| Q1: Mar 24 | $88.44 B |
$3.16 B
3.7%
|
|
Get instant access to data, Sign up for free
FY 2023
|
$357.78 B |
$35.31 B
10.95%
|
| Q4: Dec 23 | $93.81 B |
$9.97 B
11.89%
|
| Q3: Sep 23 | $89.76 B |
$8.61 B
10.6%
|
| Q2: Jun 23 | $88.92 B |
$8.29 B
10.27%
|
| Q1: Mar 23 | $85.28 B |
$8.45 B
11%
|
|
Get instant access to data, Sign up for free
FY 2022
|
$322.47 B |
$30.36 B
10.39%
|
| Q4: Dec 22 | $83.85 B |
$7.24 B
9.45%
|
| Q3: Sep 22 | $81.16 B |
$7.37 B
9.98%
|
| Q2: Jun 22 | $80.64 B |
$8.02 B
11.04%
|
| Q1: Mar 22 | $76.83 B |
$7.73 B
11.19%
|
|
Get instant access to data, Sign up for free
FY 2021
|
$292.11 B |
$23.41 B
8.71%
|
| Q4: Dec 21 | $76.60 B |
$7.05 B
10.14%
|
| Q3: Sep 21 | $73.79 B |
$6.74 B
10.05%
|
| Q2: Jun 21 | $72.62 B |
$7.28 B
11.13%
|
| Q1: Mar 21 | $69.10 B |
$2.34 B
3.51%
|
|
Get instant access to data, Sign up for free
FY 2020
|
$268.71 B |
$11.93 B
4.65%
|
| Q4: Dec 20 | $69.55 B |
$2.67 B
3.98%
|
| Q3: Sep 20 | $67.06 B |
$2.25 B
3.47%
|
| Q2: Jun 20 | $65.34 B |
$1.91 B
3.01%
|
| Q1: Mar 20 | $66.76 B |
$5.11 B
8.29%
|
|
Get instant access to data, Sign up for free
FY 2019
|
$256.78 B |
$62.20 B
31.96%
|
| Q4: Dec 19 | $66.89 B |
$11.98 B
21.82%
|
| Q3: Sep 19 | $64.81 B |
$17.32 B
36.47%
|
| Q2: Jun 19 | $63.43 B |
$16.51 B
35.18%
|
| Q1: Mar 19 | $61.65 B |
$15.90 B
34.77%
|
|
Get instant access to data, Sign up for free
FY 2018
|
$194.58 B |
$9.79 B
5.3%
|
| Q4: Dec 18 | $54.91 B |
$6.52 B
13.48%
|
| Q3: Sep 18 | $47.49 B |
$1.31 B
2.83%
|
| Q2: Jun 18 | $46.92 B |
$1.24 B
2.71%
|
| Q1: Mar 18 | $45.74 B |
$1.23 B
2.76%
|
|
Get instant access to data, Sign up for free
FY 2017
|
$184.79 B |
$7.24 B
4.08%
|
| Q4: Dec 17 | $48.39 B |
$2.41 B
5.25%
|
| Q3: Sep 17 | $46.18 B |
$1.57 B
3.51%
|
| Q2: Jun 17 | $45.69 B |
$1.96 B
4.48%
|
| Q1: Mar 17 | $44.51 B |
$1.30 B
3.01%
|
|
Get instant access to data, Sign up for free
FY 2016
|
$177.55 B |
$24.26 B
15.82%
|
| Q4: Dec 16 | $45.97 B |
$4.83 B
11.73%
|
| Q3: Sep 16 | $44.62 B |
$5.97 B
15.45%
|
| Q2: Jun 16 | $43.73 B |
$6.56 B
17.64%
|
| Q1: Mar 16 | $43.22 B |
$6.88 B
18.94%
|
Agilent Technologies Revenue
Eli Lilly and Company Revenue
Stryker Corporation Revenue
Johnson & Johnson Revenue
AbbVie Revenue
Merck & Co. Revenue
Thermo Fisher Scientific Revenue
Abbott Laboratories Revenue
Danaher Corporation Revenue
